- Home
- MPTI vs IKNA Comparison
MPTI vs IKNA Comparison
Compare MPTI & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPTI
- IKNA
- Stock Information
- Founded
- MPTI 1965
- IKNA 2016
- Country
- MPTI United States
- IKNA United States
- Employees
- MPTI N/A
- IKNA N/A
- Industry
- MPTI
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- MPTI
- IKNA Health Care
- Exchange
- MPTI Nasdaq
- IKNA Nasdaq
- Market Cap
- MPTI 117.1M
- IKNA 82.5M
- IPO Year
- MPTI N/A
- IKNA 2021
- Fundamental
- Price
- MPTI $50.49
- IKNA $1.69
- Analyst Decision
- MPTI
- IKNA Buy
- Analyst Count
- MPTI 0
- IKNA 2
- Target Price
- MPTI N/A
- IKNA $3.00
- AVG Volume (30 Days)
- MPTI 35.3K
- IKNA 34.9K
- Earning Date
- MPTI 11-07-2024
- IKNA 11-07-2024
- Dividend Yield
- MPTI N/A
- IKNA N/A
- EPS Growth
- MPTI 87.47
- IKNA N/A
- EPS
- MPTI 1.76
- IKNA N/A
- Revenue
- MPTI $44,654,000.00
- IKNA $1,844,000.00
- Revenue This Year
- MPTI $18.43
- IKNA N/A
- Revenue Next Year
- MPTI $8.16
- IKNA N/A
- P/E Ratio
- MPTI $28.53
- IKNA N/A
- Revenue Growth
- MPTI 22.02
- IKNA N/A
- 52 Week Low
- MPTI $20.90
- IKNA $1.02
- 52 Week High
- MPTI $53.04
- IKNA $4.63
- Technical
- Relative Strength Index (RSI)
- MPTI 68.80
- IKNA 41.32
- Support Level
- MPTI $45.55
- IKNA $1.68
- Resistance Level
- MPTI $53.04
- IKNA $1.74
- Average True Range (ATR)
- MPTI 3.18
- IKNA 0.04
- MACD
- MPTI 0.18
- IKNA -0.00
- Stochastic Oscillator
- MPTI 76.41
- IKNA 9.09
About MPTI M-tron Industries Inc.
M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The serving markets of the company are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.